Antimicrobial Resistance — MCQs
All are true about ESBL except -
Which of the following statements regarding resistance of penicillin in Staphylococcus aureus is false?
The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
Which of the following is NOT a criterion for defining extensively drug-resistant tuberculosis (XDR-TB)?
Antimicrobial combinations are used in all except
Identify the correct 'organism-drug to which it is intrinsically resistant' pair.
Multidrug resistance in TB is defined as resistance to
Necrotizing granulomatous inguinal lymphadenopathy is caused by which of the following?
What is the mechanism of acute rheumatic fever?
A 40-year-old man presents with a year-long history of oral candidiasis, fever, and diarrhea. Physical examination reveals muscle wasting, with his weight at 70% of normal for his height and age. He has generalized nontender lymphadenopathy but no hepatosplenomegaly. Over the past 3 months, he has developed three irregular, 1- to 2-cm, reddish-purple, nodular skin lesions on his forearm. Laboratory findings show hemoglobin, 12.2 g/dL; hematocrit, 36.5%; MCV, 85 mm3; platelet count, 188,000/mm3; and WBC count, 2460/mm3 with 82% segmented neutrophils, 4% bands, 6% lymphocytes, 6% monocytes, and 2% eosinophils. Infection with which of the following organisms is most likely to produce these findings?
Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Question 1: All are true about ESBL except -
- A. Resistant to carbapenems (Correct Answer)
- B. Classification is based on 3rd generation cephalosporin sensitivity
- C. Cephalosporin sensitivity testing is required to confirm ESBL
- D. Ambler classification is based on molecular structure
Explanation: ***Resistant to carbapenems*** - **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections. - Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs. *Classification is based on 3rd generation cephalosporin sensitivity* - ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam. - This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification. *Cephalosporin sensitivity testing is required to confirm ESBL* - **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid. - This testing is crucial for accurate detection and guiding appropriate antibiotic therapy. *Ambler classification is based on molecular structure* - The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms. - This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Question 2: Which of the following statements regarding resistance of penicillin in Staphylococcus aureus is false?
- A. Methicillin resistance is due to alterations in penicillin-binding proteins (PBPs).
- B. Penicillinase production is mediated by plasmids.
- C. Hospital strains predominantly produce a unique type of penicillinase. (Correct Answer)
- D. Penicillinase production can be transmitted by transduction.
Explanation: ***Hospital strains predominantly produce a unique type of penicillinase*** - This statement is **false** because hospital strains do not produce a truly "unique type" of **penicillinase** compared to community strains. - **Penicillinase (beta-lactamase)** is a common resistance mechanism found across various *S. aureus* strains, not exclusive to hospital environments. *Methicillin resistance is due to alterations in penicillin-binding proteins (PBPs)* - This statement is **true** as **MRSA** resistance involves the **mecA gene** encoding **PBP2a**. - **PBP2a** has low affinity for **beta-lactam antibiotics**, allowing cell wall synthesis despite antibiotic presence. *Penicillinase production is mediated by plasmids* - This statement is **true** because **penicillinase genes** are typically located on **plasmids**. - **Plasmids** facilitate horizontal transfer of resistance genes between bacterial populations. *Penicillinase production can be transmitted by transduction* - This statement is **true** as **transduction** via **bacteriophages** can transfer resistance genes. - **Plasmid-borne penicillinase genes** can spread through this horizontal gene transfer mechanism.
Question 3: The initial origin of new drug resistance genes in bacteria most commonly occurs due to:
- A. Translation
- B. Mutation (Correct Answer)
- C. Conjugation
- D. Transduction
Explanation: ***Mutation*** - **Random genetic changes** in bacteria can alter drug targets or introduce drug-inactivating enzymes, leading to resistance. - **Spontaneous mutations** in the bacterial genome are the primary source of new resistance genes that did not previously exist in the bacterial population. - While mutations occur at low frequency, they are the fundamental mechanism by which novel resistance traits first arise. *Translation* - This is the process of synthesizing proteins from mRNA; it is a fundamental cellular process and not a cause of drug resistance. - Errors in translation are generally lethal to the cell and do not typically confer specific drug-resistant phenotypes. *Conjugation* - This is a mechanism for **horizontal gene transfer** where bacteria directly transfer genetic material, including resistance genes, via a pilus. - While conjugation is the **most important mechanism for spreading resistance** in clinical settings, it transfers pre-existing resistance genes rather than creating new ones. *Transduction* - This is another form of **horizontal gene transfer** involving bacteriophages (viruses) carrying bacterial genes, including resistance genes, between bacteria. - Similar to conjugation, transduction is a mechanism for the **transfer** of pre-existing resistance genes, not their original creation.
Question 4: Which of the following is NOT a criterion for defining extensively drug-resistant tuberculosis (XDR-TB)?
- A. Isoniazid + Rifampicin + Fluoroquinolone
- B. Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone
- C. Fluoroquinolone (Correct Answer)
- D. Isoniazid + Rifampicin + Kanamycin
Explanation: ***Fluoroquinolone*** - Resistance to **fluoroquinolone alone** is NOT a criterion for XDR-TB because XDR-TB requires a **baseline of MDR-TB** (resistance to both rifampicin and isoniazid) plus additional resistances. - XDR-TB definition (WHO 2021): **MDR-TB** + resistance to **any fluoroquinolone** + resistance to **at least one Group A drug** (bedaquiline or linezolid). - Fluoroquinolone resistance in isolation does not meet any of these combined criteria. *Isoniazid + Rifampicin + Fluoroquinolone* - This represents **MDR-TB** (rifampicin + isoniazid resistance) plus **fluoroquinolone resistance**. - This is a partial criterion approaching XDR-TB but still requires additional resistance to at least one Group A drug (bedaquiline or linezolid) for complete XDR-TB classification. - However, this combination includes the essential MDR-TB base and fluoroquinolone component. *Isoniazid + Rifampicin + Ethambutol + Fluoroquinolone* - This includes **MDR-TB** (rifampicin + isoniazid), **fluoroquinolone resistance**, and ethambutol (first-line drug). - While ethambutol resistance alone doesn't define XDR-TB, this combination includes the critical MDR-TB and fluoroquinolone components required for XDR-TB classification. - Similar to above, would need Group A drug resistance for complete XDR-TB. *Isoniazid + Rifampicin + Kanamycin* - This represents **MDR-TB** plus resistance to **kanamycin** (a second-line injectable). - Under previous WHO definitions (pre-2021), injectable resistance was part of XDR-TB criteria. - This combination includes the MDR-TB base essential for any XDR-TB classification, though it lacks fluoroquinolone resistance.
Question 5: Antimicrobial combinations are used in all except
- A. Intra abdominal infections
- B. Malaria
- C. Tuberculosis
- D. Gonorrhea (Correct Answer)
Explanation: ***Gonorrhea*** - While **gonorrhea** treatment has evolved to include **dual therapy** (e.g., ceftriaxone + azithromycin), this is primarily for co-treatment of potential Chlamydia co-infection and to combat emerging resistance, given as a **single-session treatment**. - Unlike the other conditions, gonorrhea does not require a **prolonged multi-drug regimen** with true synergy or prevention of resistance development during treatment. - The combination is more about empiric co-coverage and resistance concerns rather than the classic indications for antimicrobial combinations (synergy, preventing resistance emergence during therapy, polymicrobial coverage). - This distinguishes it from conditions requiring extended combination therapy. *Intra-abdominal infections* - Involve **polymicrobial etiology** requiring combination therapy to cover both aerobic (e.g., Enterobacteriaceae) and anaerobic bacteria (e.g., Bacteroides fragilis). - Combination therapy ensures broad-spectrum coverage for mixed infections and prevents treatment failures in complex intra-abdominal sepsis. *Malaria* - **Artemisinin-based combination therapies (ACTs)** are the standard first-line treatment for uncomplicated *Plasmodium falciparum* malaria. - Combination therapy reduces drug resistance risk and improves cure rates by targeting different mechanisms of action against the parasite. *Tuberculosis* - Treatment always involves **multi-drug regimen** (isoniazid, rifampicin, pyrazinamide, ethambutol) to prevent emergence of drug-resistant strains. - Multi-drug therapy is essential because *Mycobacterium tuberculosis* rapidly develops resistance if exposed to single agents during the prolonged treatment course.
Question 6: Identify the correct 'organism-drug to which it is intrinsically resistant' pair.
- A. Candida krusei - Fluconazole (Correct Answer)
- B. Candida albicans - Amphotericin B
- C. Aspergillus fumigatus - Micafungin
- D. Aspergillus niger - Voriconazole
Explanation: ***Candida krusei - Fluconazole*** - **Candida krusei** is intrinsically resistant to **fluconazole** due to reduced affinity of its target enzyme, **lanosterol 14-alpha demethylase**, for the drug. - This resistance is a natural characteristic of the species, meaning it is inherent and not acquired through exposure. *Aspergillus fumigatus - Micafungin* - **Aspergillus fumigatus** is generally susceptible to **micafungin**, an **echinocandin drug** that targets fungal cell wall synthesis. - While resistance can develop, it is not an intrinsic characteristic of *A. fumigatus* to micafungin. *Candida albicans - Amphotericin B* - **Candida albicans** is typically susceptible to **amphotericin B**, a polyene antifungal that binds to ergosterol in the fungal cell membrane. - Intrinsic resistance to amphotericin B in *C. albicans* is rare, though acquired resistance can occur. *Aspergillus niger - Voriconazole* - **Aspergillus niger** is usually susceptible to **voriconazole**, a broad-spectrum triazole antifungal. - There is no known intrinsic resistance of *A. niger* to voriconazole.
Question 7: Multidrug resistance in TB is defined as resistance to
- A. Isoniazid and Rifampicin (Correct Answer)
- B. Streptomycin, Rifampicin and Isoniazid
- C. Streptomycin and Rifampicin
- D. Streptomycin and Isoniazid
Explanation: ***Isoniazid and Rifampicin*** - **Multidrug-resistant tuberculosis (MDR-TB)** is specifically defined by resistance to at least these two most potent first-line anti-tuberculosis drugs. - This resistance significantly complicates treatment, as these drugs form the cornerstone of standard TB therapy. *Streptomycin, Rifampicin and Isoniazid* - While resistance to these three drugs would certainly indicate a severe form of resistance, the definition of MDR-TB minimally requires resistance to **rifampicin** and **isoniazid** only. - Adding streptomycin to the definition describes an even more extensive drug resistance, but not the baseline for MDR-TB. *Streptomycin and Rifampicin* - Resistance to **streptomycin** and **rifampicin** without mention of isoniazid does not fulfill the definition of MDR-TB. - **Isoniazid** resistance is a crucial component of the MDR-TB definition alongside rifampicin. *Streptomycin and Isoniazid* - This combination lacks resistance to **rifampicin**, which is one of the two essential drugs for defining MDR-TB. - Resistance to **rifampicin** and **isoniazid** together is the key criterion.
Question 8: Necrotizing granulomatous inguinal lymphadenopathy is caused by which of the following?
- A. Syphilis (Correct Answer)
- B. Granuloma inguinale
- C. Sarcoidosis
- D. All of the above
Explanation: **Explanation:** The correct answer is **Syphilis (Option A)**. In the primary and secondary stages of Syphilis (caused by *Treponema pallidum*), the regional lymph nodes (inguinal) typically show non-specific lymphadenitis. However, in some cases, particularly in the tertiary stage or as a specific immune response, syphilis can present with **necrotizing granulomatous inflammation**. Histologically, these are characterized by "gummas"—central zones of coagulative necrosis surrounded by mononuclear cells, plasma cells (a hallmark of syphilis), and fibroblasts [2]. The presence of obliterative endarteritis in the surrounding vessels is a key diagnostic clue [1]. **Why other options are incorrect:** * **Granuloma Inguinale (Donovanosis):** Caused by *Klebsiella granulomatis*, this condition is characterized by chronic spreading ulcerations. Histologically, it shows **pseudoepitheliomatous hyperplasia** and the presence of **Donovan bodies** (intracytoplasmic inclusions in macrophages) rather than necrotizing granulomas. * **Sarcoidosis:** While sarcoidosis is a classic granulomatous disease, it characteristically produces **non-caseating (non-necrotizing)** granulomas. Furthermore, it rarely presents as isolated inguinal lymphadenopathy; it more commonly involves hilar lymph nodes and the lungs. **High-Yield Clinical Pearls for NEET-PG:** * **Plasma cell infiltration** is the histological "signature" of syphilitic lesions [2]. * **Lymphogranuloma Venereum (LGV):** Often confused with this topic, LGV (caused by *Chlamydia trachomatis* L1-L3) causes "Stellate abscesses" within the lymph nodes [3]. * **Cat-scratch disease** also causes necrotizing granulomas in lymph nodes, but these are typically axillary or cervical and show a characteristic "stellate" (star-shaped) necrotic center. * **Silver stains (Warthin-Starry)** are used to visualize the spirochetes in syphilitic tissues [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 388-389. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 386-388. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 504-505.
Question 9: What is the mechanism of acute rheumatic fever?
- A. Cross-reactivity with endogenous antigen (Correct Answer)
- B. Innocent bystander effect
- C. Due to toxin secretion by streptococci
- D. Release of pyrogenic cytokines
Explanation: ### Explanation **Correct Answer: A. Cross-reactivity with endogenous antigen** The pathogenesis of Acute Rheumatic Fever (ARF) is based on the concept of **Molecular Mimicry** (Type II Hypersensitivity). Following an infection with **Group A Beta-Hemolytic Streptococci (GABHS)**, the body produces antibodies against the streptococcal **M-protein** [1]. Because the M-protein shares structural homology with human molecules, these antibodies "cross-react" with endogenous antigens [2]. Specifically, they target **cardiac myosin**, sarcolemmal membrane proteins, and valvular glycoproteins, leading to the characteristic inflammatory lesions (Aschoff bodies) in the heart [1]. **Analysis of Incorrect Options:** * **B. Innocent bystander effect:** This refers to tissue damage where healthy cells are destroyed during an immune response against a nearby pathogen (often seen in Type III hypersensitivity or viral infections). ARF is a direct autoimmune attack due to structural similarity, not collateral damage. * **C. Due to toxin secretion:** While streptococci produce toxins (like Streptolysin O or Erythrogenic toxin), these cause direct tissue damage (e.g., Scarlet Fever or Toxic Shock Syndrome) rather than the delayed, immune-mediated multi-system inflammation seen in ARF. * **D. Release of pyrogenic cytokines:** While cytokines mediate the resulting fever and inflammation, they are the *mediators* of the response, not the primary *mechanism* of disease initiation. **High-Yield Clinical Pearls for NEET-PG:** * **Latent Period:** ARF typically occurs 2–3 weeks after streptococcal pharyngitis (never after skin infections like impetigo). * **Jones Criteria:** Diagnosis is clinical, requiring 2 Major or 1 Major + 2 Minor criteria plus evidence of preceding GABHS infection. * **Pathognomonic Feature:** **Aschoff bodies** (granulomatous foci) containing **Anitschkow cells** ("caterpillar cells" with condensed chromatin) [1]. * **Most Common Valve Involved:** Mitral valve (Mitral Regurgitation in acute phase; Mitral Stenosis in chronic phase). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 566. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 65-66.
Question 10: A 40-year-old man presents with a year-long history of oral candidiasis, fever, and diarrhea. Physical examination reveals muscle wasting, with his weight at 70% of normal for his height and age. He has generalized nontender lymphadenopathy but no hepatosplenomegaly. Over the past 3 months, he has developed three irregular, 1- to 2-cm, reddish-purple, nodular skin lesions on his forearm. Laboratory findings show hemoglobin, 12.2 g/dL; hematocrit, 36.5%; MCV, 85 mm3; platelet count, 188,000/mm3; and WBC count, 2460/mm3 with 82% segmented neutrophils, 4% bands, 6% lymphocytes, 6% monocytes, and 2% eosinophils. Infection with which of the following organisms is most likely to produce these findings?
- A. Hepatitis C virus
- B. Herpes simplex virus
- C. HIV (Correct Answer)
- D. Mycobacterium leprae
Explanation: **Explanation:** The clinical presentation is a classic case of **Acquired Immunodeficiency Syndrome (AIDS)** caused by **HIV**. The diagnosis is established through a constellation of findings: 1. **Opportunistic Infection:** Recurrent oral candidiasis in an adult is a major red flag for immunosuppression [1]. 2. **Wasting Syndrome:** Weight loss to 70% of normal (Cachexia) is a WHO clinical stage 4 defining criterion for AIDS [1]. 3. **Kaposi Sarcoma (KS):** The "reddish-purple, nodular skin lesions" are pathognomonic for KS, caused by **HHV-8** in the setting of HIV infection [2]. 4. **Lymphopenia:** The WBC count is 2460/mm³ with only 6% lymphocytes, resulting in an absolute lymphocyte count (ALC) of **147/mm³**. An ALC <1500/mm³ (specifically a CD4+ count <200/mm³) is diagnostic of the profound immunosuppression seen in HIV [3]. **Analysis of Incorrect Options:** * **Hepatitis C Virus:** Primarily causes chronic hepatitis, cirrhosis, or hepatocellular carcinoma. While it can cause cryoglobulinemia, it does not present with opportunistic infections or Kaposi-like lesions. * **Herpes Simplex Virus:** Typically causes vesicular/ulcerative lesions (cold sores or genital herpes). While common in HIV patients, it does not explain the systemic wasting or the nodular vascular tumors. * **Mycobacterium leprae:** Causes Leprosy, characterized by hypopigmented patches, nerve thickening, and skin nodules (in lepromatous leprosy), but not generalized lymphadenopathy, profound lymphopenia, or oral candidiasis. **NEET-PG High-Yield Pearls:** * **Kaposi Sarcoma:** Look for "spindle cells," "slit-like vascular spaces," and "extravasated RBCs" on histology. * **HIV Indicators:** Generalized nontender lymphadenopathy (Persistent Generalized Lymphadenopathy - PGL) is often the earliest clinical sign of HIV [3]. * **CD4+ Thresholds:** Oral Candidiasis (<250-500 cells/mm³); Kaposi Sarcoma (<200 cells/mm³); CMV Retinitis/MAC (<50 cells/mm³). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 260-261. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 261-262. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 259-260.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free